Sygehus Lillebaelt Vejle Sygehus
- Address
- lock Available on a paid plan
Hematology and Oncology Research
At Sygehus Lillebaelt Vejle Sygehus, clinical trials in hemic and lymphatic diseases and neoplasms focus on improving care for blood cancers and other malignancies. The studies are designed to test new treatment strategies, compare existing therapies, and better understand how to control disease progression and support patient outcomes.
- Research in multiple myeloma is evaluating ways to reduce infections and early complications in patients who are newly diagnosed and not eligible for transplant.
- Trials in diffuse large B-cell lymphoma are comparing treatment approaches to improve disease control and extend progression-free survival.
- Studies in triple-negative breast cancer are assessing whether new combinations can offer better effectiveness than current standard options.
- Work in metastatic hormone-sensitive prostate cancer is examining whether adding a targeted therapy can improve control of advanced disease.
This research portfolio reflects a strong focus on finding more effective and better-tolerated cancer treatments through collaborative clinical investigation.
Respiratory and Inflammatory Disease Studies
The site is also active in respiratory tract diseases and immune-related conditions, with trials aimed at improving symptom control and reducing reliance on standard medications. These studies explore new therapies for chronic inflammatory disease while also looking at safety and patient benefit.
- In pulmonary sarcoidosis, researchers are testing a new therapy to assess safety, tolerability, and its ability to lower corticosteroid use.
- The studies are focused on finding better ways to manage persistent inflammation and improve day-to-day functioning for people with this condition.
This area of research highlights the hospital’s interest in advancing treatment options for complex lung disease and related systemic involvement.
Musculoskeletal and Orthopedic Care
Clinical research in musculoskeletal diseases at this hospital includes studies on pain relief, recovery, and patient comfort after joint surgery. The trials are aimed at improving postoperative care and identifying the safest and most effective ways to support mobility and healing.
- Research in hip and knee arthroplasties is evaluating pain management approaches after major orthopedic surgery.
- Studies in acute postoperative pain are examining how different treatment strategies can improve recovery after surgery.
- Trials comparing anesthesia approaches are looking at early mobility and faster functional recovery after joint replacement.
These projects aim to make orthopedic procedures safer, less painful, and easier to recover from for patients undergoing joint replacement.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 25 therapeutic areas and 15 of 290 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 273 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 39 by active trials.
- 1AstraZeneca AB6active
lock +38 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB18trials
lock +31 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sygehus Lillebaelt Vejle Sygehus
lock Showing 1 of 161 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab | Merck Sharp & Dohme LLC | Phase III | Recruiting | Aug 2018 | — |
IMP list
lock Showing 1 of 290 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 14 | Unknown | 2016-11-17 | 2024-08-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
